摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2R,5S)-1,2,5-三甲基哌嗪 | 1046788-78-6

中文名称
(2R,5S)-1,2,5-三甲基哌嗪
中文别名
——
英文名称
N-Methyl-trans-2,5-dimethyl-piperazin
英文别名
1,2,5-trimethyl-piperazine;(2R,5S)-1,2,5-Trimethylpiperazine
(2R,5S)-1,2,5-三甲基哌嗪化学式
CAS
1046788-78-6
化学式
C7H16N2
mdl
——
分子量
128.217
InChiKey
CDHYSFKPWCVXHZ-NKWVEPMBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    9
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    15.3
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (2R,5S)-1,2,5-三甲基哌嗪4-氯二苯氯甲烷 在 sodium carbonate 、 xylene 作用下, 生成 *optically inactive 1-(4-chloro-benzhydryl)-2r,4,5t-trimethyl-piperazine
    参考文献:
    名称:
    Histamine Antagonists. IV. C-Methyl Derivatives of 1,4-Disubstituted Piperazines1
    摘要:
    DOI:
    10.1021/ja01123a008
  • 作为产物:
    描述:
    ethyl trans-2,5-dimethyl-1-piperazinecarboxylate 在 盐酸甲酸 作用下, 生成 (2R,5S)-1,2,5-三甲基哌嗪
    参考文献:
    名称:
    Histamine Antagonists. IV. C-Methyl Derivatives of 1,4-Disubstituted Piperazines1
    摘要:
    DOI:
    10.1021/ja01123a008
点击查看最新优质反应信息

文献信息

  • NOVEL 3-AMINOALKYL-1,3-DIHYDRO-2H-INDOL-2-ONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
    申请人:FOULON Loic
    公开号:US20110059955A1
    公开(公告)日:2011-03-10
    The present invention relates to novel 3-aminoalkyl-1,3-dihydro-2H-indol-2-one derivatives, to their preparation and to their therapeutic application. The compounds of the present invention correspond to the formula (I): in which the variables are as set forth in the specification. These compounds exhibit a strong affinity and a high selectivity for human arginine-vasopressin (AVP) V 1a receptors and some compounds additionally exhibit a strong affinity for AVP V 1b receptors.
    本发明涉及新颖的3-氨基烷基-1,3-二氢-2H-吲哚-2-酮衍生物,其制备以及其治疗应用。本发明的化合物对应于式(I): 其中变量如规范中所述。这些化合物表现出对人类精氨酸加压素(AVP)V1a受体具有强亲和力和高选择性,而且一些化合物还表现出对AVP V1b受体具有强亲和力。
  • [EN] HETEROARYL COMPOUNDS AND THEIR USE AS THERAPEUTIC DRUGS<br/>[FR] COMPOSÉS HÉTÉROARYLE ET LEUR UTILISATION COMME MÉDICAMENTS THÉRAPEUTIQUES
    申请人:DONG-A SOCIO HOLDINGS CO LTD
    公开号:WO2017039331A1
    公开(公告)日:2017-03-09
    The present invention provides heterocyclic compounds, the stereoisomer thereof, the enantiomer thereof, or the pharmaceutically acceptable salt, which are capable of modulating the activity of Mer receptor tyrosine kinase (MERTK). This invention also provides pharmaceutical compositions thereof, methods to prepare the said compounds, and the use of such compounds as a medicament. The present invention is directed to MERTK inhibitory compounds with marked potency, thereby having an outstanding potential for a pharmaceutical intervention of cancer and any other diseases related to MERTK dysregulation.
    本发明提供了一种杂环化合物、其立体异构体、对映异构体或药用可接受的盐,这些化合物能够调节Mer受体酪氨酸激酶(MERTK)的活性。本发明还提供了这些化合物的药物组合物、制备所述化合物的方法以及将这些化合物用作药物的应用。本发明针对的是具有显著活性的MERTK抑制性化合物,因此具有在癌症和任何与MERTK调控失调相关的疾病中进行药物干预的卓越潜力。
  • PYRAZOLO[1,5-A]PYRIMIDINES AS ANTIVIRAL AGENTS
    申请人:Gilead Sciences, Inc.
    公开号:US20130164280A1
    公开(公告)日:2013-06-27
    The invention provides compounds and pharmaceutically acceptable salts and esters and compositions thereof, for treating viral infections. The compounds and compositions are useful for treating Pneumovirinae virus infection including Human respiratory syncytial virus infections.
    该发明提供了用于治疗病毒感染的化合物、药物可接受的盐和酯以及它们的组合物。这些化合物和组合物对于治疗包括人类呼吸道合胞病毒感染在内的肺病毒亚科病毒感染是有用的。
  • [EN] PEPTIDE DEFORMYLASE INHIBITORS<br/>[FR] INHIBITEURS DE LA PEPTIDE DÉFORMYLASE
    申请人:SMITHKLINE BEECHAM CORP
    公开号:WO2009061879A1
    公开(公告)日:2009-05-14
    The present invention is directed to certain 2-(alkyl)-3-[2-(5-fluoro-4-pyrimidinyl)hydrazino]-3-oxopropyl}hydroxyformamide derivatives, compositions containing them, the use of such compounds in the inhibition of bacterial peptide deformylase (PDF) activity, and in the treatment of bacterial infections. Specifically, the invention is directed to compounds of formula (I), wherein R1, R2 and R3 are defined herein and to pharmaceutically acceptable salts thereof. The compounds of this invention are bacterial peptide deformylase inhibitors and can be useful in the treatment of bacterial infections.
    本发明涉及某些2-(烷基)-3-[2-(5-氟-4-嘧啶基)肼基]-3-氧代丙基}羟甲酰胺衍生物,含有它们的组合物,以及这些化合物在抑制细菌肽变形酶(PDF)活性和治疗细菌感染中的用途。具体而言,该发明涉及式(I)的化合物,其中R1、R2和R3在此有定义,并且其药用盐。本发明的这些化合物是细菌肽变形酶抑制剂,可用于治疗细菌感染。
  • PEPTIDE DEFORMYLASE INHIBITORS
    申请人:Qin Donghui
    公开号:US20090306066A1
    公开(公告)日:2009-12-10
    The present invention is directed to certain 2-(alkyl)-3-[2-(5-fluoro-4-pyrimidinyl)hydrazino]-3-oxopropyl}hydroxyformamide derivatives, compositions containing them, the use of such compounds in the inhibition of bacterial peptide deformylase (PDF) activity, and in the treatment of bacterial infections. Specifically, the invention is directed to compounds of formula (I): wherein R1, R2 and R3 are defined herein and to pharmaceutically acceptable salts thereof. The compounds of this invention are bacterial peptide deformylase inhibitors and can be useful in the treatment of bacterial infections.
    本发明涉及某些2-(烷基)-3-[2-(5-氟-4-嘧啶基)肼基]-3-氧代丙基}羟基甲酰胺衍生物,包含它们的组合物,这些化合物在抑制细菌肽变形酶(PDF)活性和治疗细菌感染方面的使用。具体而言,本发明涉及式(I)的化合物:其中R1,R2和R3在此定义,并且其药学上可接受的盐。本发明的化合物是细菌肽变形酶抑制剂,可用于治疗细菌感染。
查看更多